Axsome Therapeutics
AXSM
AXSM
275 hedge funds and large institutions have $3.44B invested in Axsome Therapeutics in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 83 increasing their positions, 93 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.02% less ownership
Funds ownership: 85.77% → 79.74% (-6%)
11% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 93
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
275
Holding in Top 10
8
Calls
$95.7M
Puts
$94M
Top Buyers
| 1 | +$29.1M | |
| 2 | +$22.8M | |
| 3 | +$22.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.7M |
Top Sellers
| 1 | -$89.5M | |
| 2 | -$64.3M | |
| 3 | -$40.3M | |
| 4 |
RI
RTW Investments
New York
|
-$40M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$24.1M |